vision loss tirzepatide reduces food intake and appetite, and affects brain functioning, more than placebo and liraglutide tirzepatide and vision loss can

While both peripheral IR and BIR may involve dysregulated insulin signaling, the two conditions are not identical and not always interrelated

These experimental compounds work through various proposed mechanisms, such as stimulating melanocortin receptors in the brain, but lack robust clinical evidence and carry significant safety concerns

This hormone is released in your gut after you eat

If you experience any suspected side effects from your GLP-1 medication, you can report these through the MHRA Yellow Card Scheme

Some medication labels also warn about more severe risks, including pancreatitis, gallbladder disease, acute kidney injury, and hypersensitivity reactions

Tirzepatide adds GIPR receptor activation, which enhances insulin secretion further and may amplify appetite suppression through additional neural pathways